TARSUS PHARMACEUTICALS, INC. Foreign Currency Transaction Gain (Loss), Unrealized
TARSUS PHARMACEUTICALS, INC. (TARS) reported Foreign Currency Transaction Gain (Loss), Unrealized of $10.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2026-08-06
- TARSUS PHARMACEUTICALS, INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2025-09-30 was $12.00K.
- TARSUS PHARMACEUTICALS, INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2024-09-30 was -$9.00K.
- TARSUS PHARMACEUTICALS, INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2024-06-30 was $2.00K, a 88.24% decline year-over-year.
- TARSUS PHARMACEUTICALS, INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2024-03-31 was $0.00.
- TARSUS PHARMACEUTICALS, INC. foreign currency transaction gain (loss), unrealized for fiscal 2023 was $0.00.
- TARSUS PHARMACEUTICALS, INC. foreign currency transaction gain (loss), unrealized for fiscal 2022 was -$1.00K, a 150.00% decline from fiscal 2021.
- TARSUS PHARMACEUTICALS, INC. foreign currency transaction gain (loss), unrealized for fiscal 2021 was $2.00K.
- TARSUS PHARMACEUTICALS, INC. foreign currency transaction gain (loss), unrealized for fiscal 2020 was $0.00.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.00K 10-Q · filed 2026-08-06 | |||
| 2025-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$14.00K 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | -$26.00K 10-Q · filed 2026-08-06 | |||
| 2024-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$7.00K derived: sum of 2 quarters · filed 2025-11-04 | -$7.00K 10-Q · filed 2025-11-04 | -$7.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $2.00K 10-Q · filed 2025-08-06 | $2.00K derived: sum of 3 quarters · filed 2025-08-06 | $1.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2024-05-08 | -$1.00K derived: sum of 3 quarters · filed 2024-11-13 | $16.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$1.00K derived: sum of 2 quarters · filed 2024-11-13 | $16.00K derived: sum of 3 quarters · filed 2024-11-13 | $0.00 10-K · filed 2024-02-27 |
| 2023-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $16.00K derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | -$2.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.00K 10-Q · filed 2024-08-08 | -$1.00K derived: sum of 3 quarters · filed 2024-08-08 | -$1.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$16.00K 10-Q · filed 2024-05-08 | -$18.00K derived: sum of 2 quarters · filed 2024-05-08 | -$18.00K derived: sum of 3 quarters · filed 2024-05-08 | -$16.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$2.00K derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | -$1.00K 10-K · filed 2024-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.00K 10-Q · filed 2023-11-09 | -$1.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.00K 10-Q · filed 2023-08-10 | -$1.00K derived: sum of 3 quarters · filed 2023-08-10 | -$5.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$1.00K 10-Q · filed 2023-05-09 | -$3.00K derived: sum of 2 quarters · filed 2023-05-09 | -$7.00K derived: sum of 3 quarters · filed 2023-05-09 | -$34.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | -$6.00K derived: sum of 2 quarters · filed 2023-03-17 | -$33.00K derived: sum of 3 quarters · filed 2023-03-17 | $2.00K 10-K · filed 2023-03-17 |
| 2021-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$31.00K derived: sum of 2 quarters · filed 2022-11-09 | $4.00K 10-Q · filed 2022-11-09 | $4.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $8.00K 10-Q · filed 2022-08-11 | $8.00K derived: sum of 3 quarters · filed 2022-08-11 | $8.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $35.00K 10-Q · filed 2022-05-11 | $35.00K derived: sum of 2 quarters · filed 2022-05-11 | $35.00K derived: sum of 3 quarters · filed 2022-05-11 | $35.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $0.00 derived: sum of 2 quarters · filed 2022-03-14 | $0.00 derived: sum of 3 quarters · filed 2022-03-14 | $0.00 10-K · filed 2022-03-14 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |